Discovery of novel nerve cell modulator offers potential for mood disorders, epilepsy treatmentsAugust 06, 2007Study shows link between gut protein and brain's natural marijuana-like compounds Irvine, Calif. - The discovery of a novel molecular switch that powerfully modulates nerve cell activity offers the potential for new mood disorder and epilepsy treatments, University of California, Irvine researchers report. The researchers looked at the role of the natural substance cholecystokinin (CCK) in modulating communication between cells in the brain. CCK, originally isolated from the digestive tract, is one of the most abundant small proteins, or peptides, in the brain, and it is linked to psychiatric disorders such as anxiety, depression, and schizophrenia.
The study appears as an Advanced Online Publication in Nature Neuroscience. Using sophisticated electrophysiological measurements, the UC Irvine team showed that CCK functions in the brain as an extremely specific switch with a highly unusual, dual action. On the one hand, CCK enhances the synthesis and release of natural marijuana-like (endocannabinoid) substances from a particular class of nerve cells known to modulate neuronal excitability in brain circuits critical for cognition and mood. On the other hand, CCK robustly increases electrical activity in a different class of nerve cells that play critical roles in learning and memory. "These results reveal a new mechanism for CCK to regulate nerve cell activity in a highly specific manner," said Csaba Foldy, postdoctoral researcher in anatomy and neurobiology and lead author of the study. The study looked at the hippocampus, the region of the brain involved in learning, memory and emotion. Damage or alterations to the hippocampus can cause cognitive disorders, epilepsy, and mental illness. "By linking CCK actions to endocannabinoids, the study provides novel possibilities for the future development of therapies for a number of neurological diseases," said Ivan Soltesz, professor and chair of the Department of Anatomy and Neurobiology and senior author of the study. "Cannabinoid compounds are interesting because they act through special receptors on nerve cells to modulate these cells' behavior." "This discovery offers the potential for new drug therapies because the link between CCK and cannabinoids can now be further investigated to determine how its modulation by either pharmacological or genetic means alters excitability in the hippocampus," he added. University of California - Irvine | |||||||||||||||||||||
|
Related Nerve Cell Current Events and Nerve Cell News Articles In the war against diseases, nerve cells need their armor In a new study, researchers at the Montreal Neurological Institute (MNI), McGill University, and the Université de Montréal have discovered an essential mechanism for the maintenance of the normal structure of myelin, the protective covering that insulates and supports nerve cells (neurons). What makes an axon an axon? Inside every axon is a dendrite waiting to get out. Hedstrom et al. converted mature axons into dendrites by banishing a protein crucial for neuron development. Protein shown to play a key role in normal development of nervous system A protein that enables nerve cells to communicate with each other plays a key role in controlling the developing nervous system. New study proves that pain is not a symptom of arthritis, pain causes arthritis Pain is more than a symptom of osteoarthritis, it is an inherent and damaging part of the disease itself, according to a study published today in journal Arthritis and Rheumatism. MS patients have higher spinal fluid levels of suspicious immune molecule A protein that helps keep immune cells quiet is more abundant in the spinal fluid of patients with multiple sclerosis (MS), further boosting suspicion that the protein, TREM-2, may be an important contributor to the disease. Inflammatory response to infection and injury may worsen dementia Inflammation in the brain resulting from infection or injury may accelerate the progress of dementia, research funded by the Wellcome Trust suggests. Penn study finds way to prevent protein clumping characteristic of Parkinson's disease Researchers at the University of Pennsylvania School of Medicine have identified a protein from a most unlikely source -- baker's yeast -- that might protect against Parkinson's disease. Angiotensin receptor blockers are lower incidence, progression of Alzheimer's disease Researchers at Boston University School of Medicine (BUSM) have, for the first time, found that angiotensin receptor blockers (ARBs)-a particular class of anti-hypertensive medicines-are associated with a striking decrease in the occurrence and progression of dementia. Data from this study will be presented this weekend (July 27) at the 2008 International Conference on Alzheimer's disease in Chicago. NIST membrane model may unlock secrets of early-stage Alzheimer's Researchers at the National Institute of Standards and Technology (NIST) and three collaborating institutions are using a new laboratory model of the membrane surrounding neurons in the brain to study how a protein long suspected of a role in early-stage Alzheimer's disease actually impairs a neuron's structure and function. 'Stuffy nose' mouse: A promise to help treat 31 million with sinusitis Mice with inflamed nasal tissue being tested at a Johns Hopkins laboratory may be unable to tell if something smells bad or good, but their sensory deficit is nothing to turn up a nose at. More Nerve Cell Current Events and Nerve Cell News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||